Immuno-Cell Therapy Market - Global Outlook and Forecast 2021-2027

April 2021 | 108 pages | ID: IEC94A1654B9EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Immuno-Cell Therapy in Global, including the following market information:

Global Immuno-Cell Therapy Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Immuno-Cell Therapy market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immuno-Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Immuno-Cell Therapy Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Immuno-Cell Therapy Market Segment Percentages, By Type, 2020 (%)

• Passive Immune (NK, LAK etc)
• Active Immune

China Immuno-Cell Therapy Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Immuno-Cell Therapy Market Segment Percentages, By Application, 2020 (%)

• Oncology
• Cardiovascular Disease (CVD)
• Orthopedic
• Wound Healing
• Others

Global Immuno-Cell Therapy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Immuno-Cell Therapy Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Immuno-Cell Therapy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Immuno-Cell Therapy Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• MEDINET Co
• Erytech
• Seta Clinic Group
• Takeda
• SBI Holdings
• Oxford BioTherapeutics
• Fate Therapeutics
• Gilead Sciences
• Novartis
• Osiris
• Vericel Corporation
• Fujifilm Cellular Dynamics
• JCR Pharmaceuticals
• Beike Biotechnology
• Golden Meditech
• Guanhao Biotech
• Beroni Group

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Perfluoroketones Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Perfluoroketones Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PERFLUOROKETONES OVERALL MARKET SIZE

2.1 Global Perfluoroketones Market Size: 2021 VS 2027
2.2 Global Perfluoroketones Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Perfluoroketones Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Perfluoroketones Players in Global Market
3.2 Top Global Perfluoroketones Companies Ranked by Revenue
3.3 Global Perfluoroketones Revenue by Companies
3.4 Global Perfluoroketones Sales by Companies
3.5 Global Perfluoroketones Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Perfluoroketones Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Perfluoroketones Product Type
3.8 Tier 1, Tier 2 and Tier 3 Perfluoroketones Players in Global Market
  3.8.1 List of Global Tier 1 Perfluoroketones Companies
  3.8.2 List of Global Tier 2 and Tier 3 Perfluoroketones Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Perfluoroketones Market Size Markets, 2021 & 2027
  4.1.2 C4
  4.1.3 C5
  4.1.4 C6
  4.1.5 C7
  4.1.6 Others
4.2 By Type - Global Perfluoroketones Revenue & Forecasts
  4.2.1 By Type - Global Perfluoroketones Revenue, 2016-2021
  4.2.2 By Type - Global Perfluoroketones Revenue, 2022-2027
  4.2.3 By Type - Global Perfluoroketones Revenue Market Share, 2016-2027
4.3 By Type - Global Perfluoroketones Sales & Forecasts
  4.3.1 By Type - Global Perfluoroketones Sales, 2016-2021
  4.3.2 By Type - Global Perfluoroketones Sales, 2022-2027
  4.3.3 By Type - Global Perfluoroketones Sales Market Share, 2016-2027
4.4 By Type - Global Perfluoroketones Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Perfluoroketones Market Size, 2021 & 2027
  5.1.2 Extinguishing Agent
  5.1.3 Cleaning Agent
  5.1.4 Refrigerants
  5.1.5 Others
5.2 By Application - Global Perfluoroketones Revenue & Forecasts
  5.2.1 By Application - Global Perfluoroketones Revenue, 2016-2021
  5.2.2 By Application - Global Perfluoroketones Revenue, 2022-2027
  5.2.3 By Application - Global Perfluoroketones Revenue Market Share, 2016-2027
5.3 By Application - Global Perfluoroketones Sales & Forecasts
  5.3.1 By Application - Global Perfluoroketones Sales, 2016-2021
  5.3.2 By Application - Global Perfluoroketones Sales, 2022-2027
  5.3.3 By Application - Global Perfluoroketones Sales Market Share, 2016-2027
5.4 By Application - Global Perfluoroketones Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Perfluoroketones Market Size, 2021 & 2027
6.2 By Region - Global Perfluoroketones Revenue & Forecasts
  6.2.1 By Region - Global Perfluoroketones Revenue, 2016-2021
  6.2.2 By Region - Global Perfluoroketones Revenue, 2022-2027
  6.2.3 By Region - Global Perfluoroketones Revenue Market Share, 2016-2027
6.3 By Region - Global Perfluoroketones Sales & Forecasts
  6.3.1 By Region - Global Perfluoroketones Sales, 2016-2021
  6.3.2 By Region - Global Perfluoroketones Sales, 2022-2027
  6.3.3 By Region - Global Perfluoroketones Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Perfluoroketones Revenue, 2016-2027
  6.4.2 By Country - North America Perfluoroketones Sales, 2016-2027
  6.4.3 US Perfluoroketones Market Size, 2016-2027
  6.4.4 Canada Perfluoroketones Market Size, 2016-2027
  6.4.5 Mexico Perfluoroketones Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Perfluoroketones Revenue, 2016-2027
  6.5.2 By Country - Europe Perfluoroketones Sales, 2016-2027
  6.5.3 Germany Perfluoroketones Market Size, 2016-2027
  6.5.4 France Perfluoroketones Market Size, 2016-2027
  6.5.5 U.K. Perfluoroketones Market Size, 2016-2027
  6.5.6 Italy Perfluoroketones Market Size, 2016-2027
  6.5.7 Russia Perfluoroketones Market Size, 2016-2027
  6.5.8 Nordic Countries Perfluoroketones Market Size, 2016-2027
  6.5.9 Benelux Perfluoroketones Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Perfluoroketones Revenue, 2016-2027
  6.6.2 By Region - Asia Perfluoroketones Sales, 2016-2027
  6.6.3 China Perfluoroketones Market Size, 2016-2027
  6.6.4 Japan Perfluoroketones Market Size, 2016-2027
  6.6.5 South Korea Perfluoroketones Market Size, 2016-2027
  6.6.6 Southeast Asia Perfluoroketones Market Size, 2016-2027
  6.6.7 India Perfluoroketones Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Perfluoroketones Revenue, 2016-2027
  6.7.2 By Country - South America Perfluoroketones Sales, 2016-2027
  6.7.3 Brazil Perfluoroketones Market Size, 2016-2027
  6.7.4 Argentina Perfluoroketones Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Perfluoroketones Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Perfluoroketones Sales, 2016-2027
  6.8.3 Turkey Perfluoroketones Market Size, 2016-2027
  6.8.4 Israel Perfluoroketones Market Size, 2016-2027
  6.8.5 Saudi Arabia Perfluoroketones Market Size, 2016-2027
  6.8.6 UAE Perfluoroketones Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 3M
  7.1.1 3M Corporate Summary
  7.1.2 3M Business Overview
  7.1.3 3M Perfluoroketones Major Product Offerings
  7.1.4 3M Perfluoroketones Sales and Revenue in Global (2016-2021)
  7.1.5 3M Key News
7.2 Unimatec
  7.2.1 Unimatec Corporate Summary
  7.2.2 Unimatec Business Overview
  7.2.3 Unimatec Perfluoroketones Major Product Offerings
  7.2.4 Unimatec Perfluoroketones Sales and Revenue in Global (2016-2021)
  7.2.5 Unimatec Key News
7.3 Firecop
  7.3.1 Firecop Corporate Summary
  7.3.2 Firecop Business Overview
  7.3.3 Firecop Perfluoroketones Major Product Offerings
  7.3.4 Firecop Perfluoroketones Sales and Revenue in Global (2016-2021)
  7.3.5 Firecop Key News
7.4 Tianjin Changlu
  7.4.1 Tianjin Changlu Corporate Summary
  7.4.2 Tianjin Changlu Business Overview
  7.4.3 Tianjin Changlu Perfluoroketones Major Product Offerings
  7.4.4 Tianjin Changlu Perfluoroketones Sales and Revenue in Global (2016-2021)
  7.4.5 Tianjin Changlu Key News
7.5 Hangzhou ZeErRui Chemical Co
  7.5.1 Hangzhou ZeErRui Chemical Co Corporate Summary
  7.5.2 Hangzhou ZeErRui Chemical Co Business Overview
  7.5.3 Hangzhou ZeErRui Chemical Co Perfluoroketones Major Product Offerings
  7.5.4 Hangzhou ZeErRui Chemical Co Perfluoroketones Sales and Revenue in Global (2016-2021)
  7.5.5 Hangzhou ZeErRui Chemical Co Key News

8 GLOBAL PERFLUOROKETONES PRODUCTION CAPACITY, ANALYSIS

8.1 Global Perfluoroketones Production Capacity, 2016-2027
8.2 Perfluoroketones Production Capacity of Key Manufacturers in Global Market
8.3 Global Perfluoroketones Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 PERFLUOROKETONES SUPPLY CHAIN ANALYSIS

10.1 Perfluoroketones Industry Value Chain
10.2 Perfluoroketones Upstream Market
10.3 Perfluoroketones Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Perfluoroketones Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Immuno-Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Immuno-Cell Therapy Market Drivers in Global Market
Table 3. Immuno-Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Immuno-Cell Therapy in Global Market
Table 5. Top Immuno-Cell Therapy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Immuno-Cell Therapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Immuno-Cell Therapy Revenue Share by Companies, 2016-2021
Table 8. Global Companies Immuno-Cell Therapy Product Type
Table 9. List of Global Tier 1 Immuno-Cell Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immuno-Cell Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Immuno-Cell Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Immuno-Cell Therapy Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Immuno-Cell Therapy Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Immuno-Cell Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Immuno-Cell Therapy Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Immuno-Cell Therapy Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Immuno-Cell Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Immuno-Cell Therapy Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Immuno-Cell Therapy Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Immuno-Cell Therapy Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Immuno-Cell Therapy Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Immuno-Cell Therapy Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Immuno-Cell Therapy Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Immuno-Cell Therapy Revenue, (US$, Mn), 2022-2027
Table 30. MEDINET Co Corporate Summary
Table 31. MEDINET Co Immuno-Cell Therapy Product Offerings
Table 32. MEDINET Co Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 33. Erytech Corporate Summary
Table 34. Erytech Immuno-Cell Therapy Product Offerings
Table 35. Erytech Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 36. Seta Clinic Group Corporate Summary
Table 37. Seta Clinic Group Immuno-Cell Therapy Product Offerings
Table 38. Seta Clinic Group Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 39. Takeda Corporate Summary
Table 40. Takeda Immuno-Cell Therapy Product Offerings
Table 41. Takeda Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 42. SBI Holdings Corporate Summary
Table 43. SBI Holdings Immuno-Cell Therapy Product Offerings
Table 44. SBI Holdings Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 45. Oxford BioTherapeutics Corporate Summary
Table 46. Oxford BioTherapeutics Immuno-Cell Therapy Product Offerings
Table 47. Oxford BioTherapeutics Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 48. Fate Therapeutics Corporate Summary
Table 49. Fate Therapeutics Immuno-Cell Therapy Product Offerings
Table 50. Fate Therapeutics Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 51. Gilead Sciences Corporate Summary
Table 52. Gilead Sciences Immuno-Cell Therapy Product Offerings
Table 53. Gilead Sciences Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 54. Novartis Corporate Summary
Table 55. Novartis Immuno-Cell Therapy Product Offerings
Table 56. Novartis Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 57. Osiris Corporate Summary
Table 58. Osiris Immuno-Cell Therapy Product Offerings
Table 59. Osiris Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 60. Vericel Corporation Corporate Summary
Table 61. Vericel Corporation Immuno-Cell Therapy Product Offerings
Table 62. Vericel Corporation Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 63. Fujifilm Cellular Dynamics Corporate Summary
Table 64. Fujifilm Cellular Dynamics Immuno-Cell Therapy Product Offerings
Table 65. Fujifilm Cellular Dynamics Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 66. JCR Pharmaceuticals Corporate Summary
Table 67. JCR Pharmaceuticals Immuno-Cell Therapy Product Offerings
Table 68. JCR Pharmaceuticals Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 69. Beike Biotechnology Corporate Summary
Table 70. Beike Biotechnology Immuno-Cell Therapy Product Offerings
Table 71. Beike Biotechnology Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 72. Golden Meditech Corporate Summary
Table 73. Golden Meditech Immuno-Cell Therapy Product Offerings
Table 74. Golden Meditech Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 75. Guanhao Biotech Corporate Summary
Table 76. Guanhao Biotech Immuno-Cell Therapy Product Offerings
Table 77. Guanhao Biotech Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 78. Beroni Group Corporate Summary
Table 79. Beroni Group Immuno-Cell Therapy Product Offerings
Table 80. Beroni Group Immuno-Cell Therapy Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Immuno-Cell Therapy Segment by Type
Figure 2. Immuno-Cell Therapy Segment by Application
Figure 3. Global Immuno-Cell Therapy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Immuno-Cell Therapy Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Immuno-Cell Therapy Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immuno-Cell Therapy Revenue in 2020
Figure 8. By Type - Global Immuno-Cell Therapy Revenue Market Share, 2016-2027
Figure 9. By Application - Global Immuno-Cell Therapy Revenue Market Share, 2016-2027
Figure 10. By Region - Global Immuno-Cell Therapy Revenue Market Share, 2016-2027
Figure 11. By Country - North America Immuno-Cell Therapy Revenue Market Share, 2016-2027
Figure 12. US Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Immuno-Cell Therapy Revenue Market Share, 2016-2027
Figure 16. Germany Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 17. France Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Immuno-Cell Therapy Revenue Market Share, 2016-2027
Figure 24. China Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 28. India Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Immuno-Cell Therapy Revenue Market Share, 2016-2027
Figure 30. Brazil Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Immuno-Cell Therapy Revenue Market Share, 2016-2027
Figure 33. Turkey Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Immuno-Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 37. MEDINET Co Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Erytech Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Seta Clinic Group Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Takeda Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. SBI Holdings Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Oxford BioTherapeutics Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Fate Therapeutics Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Gilead Sciences Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Novartis Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Osiris Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Vericel Corporation Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Fujifilm Cellular Dynamics Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. JCR Pharmaceuticals Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Beike Biotechnology Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Golden Meditech Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Guanhao Biotech Immuno-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)